How to Inject Wegovy®: A Calm Walkthrough

Choosing the site

Abdomen (away from the navel), front of thigh, or back of the upper arm. Rotate weekly so no single area takes every dose – and avoid skin that is bruised, tender, or scarred.

The routine, unhurried

Wash hands, clean the site, remove the cap, press the pen flat against skin, and hold the button until the dose window shows complete and you have counted several seconds. A drop of blood or brief sting afterward is normal.

Timing and missed doses

Same day weekly, any time of day, food irrelevant. If a dose is missed and the next scheduled dose is more than two days away, your instructions describe taking it as soon as possible; if it is closer than that, skip it. Never double up.

Sharps and storage

Store unused pens refrigerated per the label, and dispose of used pens in an FDA-cleared sharps container – never loose in household trash. See the 30-second film answers for this medication.

Administering it correctly, in plain terms

Follow the instructions your dispensing pharmacy provides with your specific preparation, because concentration differs between products and that is what determines the volume you draw. Most weekly peptide injections are subcutaneous, into fat rather than muscle, using the abdomen away from the navel, the outer thigh, or the back of the upper arm. Rotating the site each week reduces local irritation. Supplies arrive with the shipment: syringes, alcohol swabs, and a sharps container. Units and milligrams are not interchangeable, and confusing them is the most common self-administration error, which is why units versus milligrams exists as its own article. If anything about your dose, volume, or schedule is unclear, contact the pharmacy or your clinician before injecting rather than estimating.

How semaglutide works on the GLP-1 receptor

Semaglutide is a GLP-1 receptor agonist. GLP-1 is an incretin hormone your intestine releases after eating; it prompts insulin release when glucose is elevated, slows gastric emptying, and signals satiety in the hypothalamus. Semaglutide binds the same receptor, and structural modifications give it a long half-life, which is what makes once-weekly dosing possible for the injectable form. It acts on one receptor rather than two, which is the pharmacological difference from tirzepatide. According to the FDA prescribing information for semaglutide products, that mechanism is the basis of the approved indications. Oral semaglutide reaches the same receptor by a different route and carries strict dosing conditions as a result, which oral versus injectable semaglutide covers. Whether any form suits you is decided by a licensed clinician after an evaluation.

What compounded means, and what it does not

A compounded preparation is made by a licensed pharmacy for an individual patient on receipt of a valid prescription. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed. That is a statement about regulatory pathway, not an accusation about any particular pharmacy, and it is why the distinction matters more than marketing language does. A compounded preparation is not a generic and not an equivalent of any FDA-approved brand product. Published clinical trials such as STEP-1 studied the branded product at studied doses; those findings should not be assumed to transfer. What compounded means unpacks the legal framework, and red flags when buying online covers how to tell a legitimate pharmacy from a grey-market seller.

Why side effects are mostly digestive, and mostly early

Because the receptors semaglutide acts on sit in the gut and the brainstem, the predictable effects are digestive: nausea, reflux, constipation, diarrhoea, and a feeling of fullness that arrives sooner than expected. According to FDA prescribing information for semaglutide products, gastrointestinal reactions are the most commonly reported adverse events, and they are dose-related for many people. The practical implication is that they tend to cluster around a dose change rather than persist indefinitely. Serious risks are listed separately in the label, including pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumours in rodents. Those are not common, but they are the reason the medication is prescription-only. Report severe or persistent abdominal pain, vomiting that stops you keeping fluids down, or vision changes to your clinician promptly rather than waiting for a scheduled check-in.

You have read enough. A clinician reads your history and tells you honestly whether this fits.

Want a walkthrough from a real care team?

A licensed clinician reviews your history and your care team stays available by message. Rx only, refunded in full if you are not prescribed.

Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.

Sources

Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.

1. FDAFDA prescribing information and instructions for use: Wegovy
2. FDAFDA. Safely using sharps at home
3. FDA databaseDrugs@FDA: search approved labeling for semaglutide
4. Peer-reviewedSTEP-1: Once-Weekly Semaglutide in Adults with Overweight or Obesity (NEJM 2021)

Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.

More on Wegovy® Tablets

Same medication, different question.